Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Alzheimer disease”
- CommunityRx-DementiaCompleted
Sponsor: University of Chicago
Health Related Social Needs (HRSN)
United States
Sponsor: National Institute on Aging (NIA)
Alzheimer's Disease
United States
- An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease PsychosisEnrolling By Invitation
Sponsor: MapLight Therapeutics
Psychosis Associated With Alzheimer's Disease
United States, Bulgaria, France
- Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples With Implications for Alzheimer's Disease RiskEnrolling By Invitation
Sponsor: University of Utah
Sleep Apnea · Sleep Disturbance
United States
Sponsor: Deepsonbio
Mild Cognitive Impairment · Alzheimer's Disease(AD)
South Korea
Sponsor: Eli Lilly and Company
Alzheimer Disease
United States, Australia, New Zealand, Singapore
Sponsor: Immunobrain Checkpoint
Alzheimer's Disease
Israel, Netherlands, United Kingdom
Sponsor: Johns Hopkins University
Polypharmacy · Alzheimer's Disease and Related Dementias · Mild Cognitive Impairment
United States
Sponsor: Eli Lilly and Company
Alzheimer Disease
China
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)Recruiting
Sponsor: Eli Lilly and Company
Cognitive Dysfunction · Lewy Body Disease · Synucleinopathies · Amyloid
United States, Japan, South Korea, Taiwan
Sponsor: California Pacific Medical Center Research Institute
Obstructive Sleep Apnea · Cognitive Decline
United States
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States, Argentina, Brazil, Canada, China +8 more
Sponsor: University of Pittsburgh
Alzheimers Disease Related Dementias
United States
- A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRecruiting
Sponsor: Hoffmann-La Roche
Alzheimers Disease
United States, Argentina, Australia, Brazil, Canada +11 more
- Study to Evaluate the Effect of HT-4253 for the Prevention of Alzheimer's Disease in APOE4 CarriersRecruiting
Sponsor: Halia Therapeutics, Inc.
Alzheimers Disease
United Arab Emirates
- ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension StudyEnrolling By Invitation
Sponsor: ACADIA Pharmaceuticals Inc.
Alzheimer's Disease Psychosis
United States, Brazil, Bulgaria, Chile, Czechia +7 more
Sponsor: Columbia University
Parkinson Disease · Alzheimer Disease · Mild Cognitive Impairment
United States
Sponsor: Indiana University
Mild Cognitive Impairment (MCI) · Alzheimer Disease · Alzheimer's Disease (Incl Subtypes) · Dementia
United States
Sponsor: Emory University
Gait Disorders, Neurologic · Parkinson Disease
United States
Sponsor: Eidos Therapeutics, a BridgeBio company
Amyloidosis · Amyloid Cardiomyopathy · Transthyretin Amyloidosis · Cardiomyopathies
United States, Argentina, Australia, Belgium, Brazil +19 more
- Sleep Interventions and Neurocognitive OutcomesNot Yet Recruiting
Sponsor: New York State Psychiatric Institute
Sleep Disturbance · Amnestic Mild Cognitive Impairment
United States
Sponsor: Wake Forest University Health Sciences
Alzheimer Disease · Mild Cognitive Impairment
United States
- Assessing Treatment With High-phenolic EVOO Supplements for Neurovascular ActivityNot Yet Recruiting
Sponsor: Augusta University
Mild Cognitive Impairment (MCI)
United States
Sponsor: Indiana University
Dementia · Alzheimer Disease, Late Onset
United States
- To Evaluate the Safety and Efficacy of RP902 TabletsNot Yet Recruiting
Sponsor: Risen (Suzhou) Pharma Tech Co., Ltd.
Mild Cognitive Impairment (MCI)